Incidental tubal endometrioid adenocarcinoma – case report

The fallopian tubes represent a highly important structure for ovarian carcinogenesis. They provide the passage of eutopic endometrium from the uterus, as well as metastatic cells from the ovaries. A direct source of tumor cells for ovarian cancer was also recently confirmed in the fallopian tubes. The authors present a case report of an incidental tubal endometrioid carcinoma with the coexistence of adenomyosis.

Fallopian tubes; Endometrioid carcinoma; Adenomyosis.

[1] Kulac I., Usubutun A.: “Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: How effective are the macroscopic tubal sampling techniques?” J. Gynecol. Oncol., 2013, 24, 114.

[2] Koshiyama M., Matsumura N., Konishi I.: “Recent concepts of ovarian carcinogenesis: type I and type II”. Biomed. Res. Int., 2014, 2014, 934261.

[3] Maeda D., Shih leM.: “Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms”. Adv. Anat. Pathol., 2013, 20, 45.

[4] Kuhn E., Kurman R.J., Shih I.M.: “Ovarian cancer is an important disease: fact or fiction?” Curr. Obstet. Gynecol. Rep., 2012, 1, 1.

[5] Kurman R.J., Vang R., Junge J., Hannibal C.G., Kjaer S.K., Shih IeM.: “Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants,and endosalpingiosis”. Am. J. Surg. Pathol., 2011, 3, 1605.

[6] Králíčková M., Vetvicka V.: “Endometriosis and ovarian cancer”. World J. Clin. Oncol., 2014, 5, 800.

[7] Piek J.M.J., Verheijen H.M., Kenemans P., Massuger L.F., Bulten H., vanDiest P.J.: “BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis”. Gynecol. Oncol., 2003, 90, 491.

[8] Folkins A.K., Jarboe E.A., Saleemuddin A., Lee Y., Callahan M.J., Drapkin R., et al.: “A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations”. Gynecol. Oncol., 2008, 109, 168.

[9] Przybycin C.G., Kurman R.J., Ronnett B.M., Shih IeM., Vang R.: “Are all pelvic (nonuterine) serous carcinomas of tubal origin?” Am. J. Surg. Pathol., 2010, 34, 1407.

[10] Yamaguchi K., Mandai M., Toyokuni S., Hamanishi J., Higuchi T., Takakura K., Fujii S.: “Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress”. Clin. Cancer Res., 2008, 14, 32.

[11] Wei J.J., William J., Bulun S.: “Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects”. Int. J. Gynecol.Pathol., 2011, 30, 553. [12] Taga S., Sawada M., Nagai A., Yamamoto D., Hayase R.: “A case of endometrioid adenocarcinoma arising from adenomyosis”. Case Rep. Obstet. Gynecol., 2014, 2014, 569295.

[13] Kucera E., Hejda V., Dankovcik R., Valha P., Dudas M., Feyereisl J.: “Malignant changes in adenomyosis in patients with endometrioid adenocarcinoma”. Eur. J. Gynaecol. Oncol., 2011, 32, 182.

[14] Culton L.K., Deavers M.T., Silva E.G., Liu J., Malpica A.: “Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases”. Am. J. Surg. Pathol., 2006, 30, 844.